|
期刊封面： |
期刊名称：Journal of Thoracic Oncology 研究方向：RESPIRATORY SYSTEM 医学-呼吸系统 |
| ISSN: | 1556-0864 |
| E-ISSN: | 1556-1380 |
| Impact Factor： | 12.460 |
| 5-Year Impact Factor: | |
| 自引率： | 7.80% |
| h-index： | 113 |
|
CiteScore： |
14.1 |
| JCR分区： | Q1 |
| 中科院分区： | 1区 |
| 出版周期： | Monthly |
| 是否OA： | No |
| 出版年份： | 2006 |
| 出版地区： | UNITED STATES |
| 期刊官方网址： | http://www.jto.org/ |
| 期刊投稿地址： | https://www.editorialmanager.com/JTO |
| SCI期刊coverage： |
Science Citation Index Science Citation Index Expanded |
| PubMed Central (PMC)链接： | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1556-0864%5BISSN%5D |
| 审稿周期： | 3-4个月 |
| 投稿命中率： | 80%左右 |
| 期刊简介： | Journal of Thoracic Oncology (JTO), the official journal of the International Association for the Study of Lung Cancer, is the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. JTO emphasizes a multidisciplinary approach and includes original research reviews and opinion pieces. The audience includes epidemiologists, medical oncologists, radiation oncologists, thoracic surgeons, pulmonologists, radiologists, pathologists, nuclear medicine physicians, and research scientists with a special interest in thoracic oncology. The journal is interested in receiving manuscripts dealing with epidemiology, prevention, screening, early detection, staging, cure, and treatment of thoracic malignancies. Submissions on tobacco control and cessation are of interest, particularly where there is direct relevance to lung cancer epidemiology and therapeutic outcomes. The Journal also welcomes submissions on pathologic and histologic classification and novel imaging and bronchoscopic approaches. Submissions regarding novel systemic therapies, particularly in the fields of biomarker targets, genomics, immunology, and cellular therapies are of interest. Novel radiotherapy and surgical techniques are of interest. Submission of randomized phase II and phase III trials, as well as meta analyses of individual participant data, are encouraged. Basic science studies must have direct clinical and translational relevance. |
| 稿件要求： |
1、SCI稿件控制10页以上，4600单词字数以上（未翻译中文字数8600字数以上）；文章撰写语言为英语；（单栏格式，单倍行距，内容10号字体，文章内容包含：题目，所有作者姓名，作者单位，通信作者邮箱，摘要，关键词，内容，总结，项目基金，参考文献，所有作者相片+简介） 2、未一稿多投，未在其他期刊上公开发表；拒绝抄袭、机械性的稿件； 3、稿件重复率控制10%以内，论文务必保证原创性、图标、公式、引文等要素齐备，已发表或引用过度的文章将不会被出版和检索； 4、稿件必须有较好的英语表达水平，有图，有表，有公式，有数据或设计，有算法（方案，模型），实验，仿真等； 5、参考文献控制25条以上，参考文献引用一半以上控制在近5年以内；图表分辨率必须达到300dpi；参考文献与文献综述能反映国际研究前沿； 6、国家自然科学基金、科技部或教育部课题资助的论文优先； 7、论文语言需要经过国外专家翻译、润色（自行安排或由IASRS提供此项服务）； 8、投稿初稿不需要排版，审稿通过后提供期刊模版、修改意见和建议。 |
| 联系方式: |
投稿邮箱：submit@iasrs.cn（投稿邮件内容：文章领域或方向+姓名+电话+微信号+QQ号） 微信客服："SCIEI_service" 联系电话（微信同号）：(+86) 19898831008 联系人：廖编辑 |
|
期刊发表：SCI核心期刊发表，发表学术论文网站，国际论文发表，论文怎么发表，国外期刊投稿，国际论文期刊，SCI期刊推荐，国际期刊推荐，论文如何发表，发表学术论文，怎样发表学术论文，SCI论文官网，SCI论文翻译，SCI论文润色，SCI论文查重系统，期刊查询，SCI期刊源列表
地址：湖南省长沙县开元路尚鑫海悦商务楼
